 The US Supreme Court declined to hear the case, and the final decision denied the existence of a right to unapproved medications.Critics of the FDA's regulatory power argue that the FDA takes too long to approve drugs that might ease pain and human suffering faster if brought to market sooner.The AIDS crisis created some political efforts to streamline the approval process.